Is NSP a good stock to buy? We came across a bullish thesis on Insperity, Inc. on Valueinvestorsclub.com by madler934. In this article, we will summarize the bulls’ thesis on NSP. Insperity, Inc.’s share was trading at $31.42 as of April 20th. NSP’s trailing and forward P/E were 70.12 and 13.97 respectively according to Yahoo Finance.
Rawpixel.com/Shutterstock.com
Insperity, Inc. (NSP) is a leading Professional Employer Organization (PEO) operating in a complex, underfollowed industry that combines elements of HCM software, HR outsourcing, and insurance. The opportunity exists largely due to limited investor awareness, sparse sell-side coverage, and temporarily depressed earnings that inflate valuation multiples.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
While the stock trades at 13.2x 2025E EBITDA and 35.0x earnings, these figures are distorted by short-term headwinds, including elevated healthcare claims and significant Workday implementation costs, which together represent a substantial drag on profitability. As these pressures normalize, EBITDA is expected to inflect meaningfully, with potential 2.5x growth between 2025 and 2027.
Insperity’s core business serves U.S. SMBs through bundled HR solutions, leveraging its scale of over 300,000 worksite employees to offer competitively priced insurance via a self-funded model. This scale advantage creates a virtuous cycle of lower insurance costs, higher service investment, and market share gains. Despite clear value propositions, PEO penetration remains low, with only 17% adoption among target SMBs, leaving a long runway for growth. Historically, Insperity has demonstrated strong execution, delivering consistent WSE growth, margin expansion, and high capital efficiency, while returning substantial capital to shareholders.
The current earnings trough is primarily driven by cyclical healthcare cost pressures, which are industry-wide and expected to normalize through repricing and a new contract with UnitedHealth, alongside declining Workday-related investments. These factors alone could drive significant EBITDA recovery in 2026, with further upside in 2027 as margins fully normalize. Additionally, a rebound in employment-driven “change in existing” growth could provide incremental upside to consensus expectations.
Overall, the investment offers an asymmetric risk/reward profile, with normalized earnings implying substantial upside, while downside appears limited given Insperity’s historically resilient business model and consistent profitability across cycles.
Previously, we covered a bullish thesis on Automatic Data Processing, Inc. (ADP) by David in November 2024, which highlighted the company’s global leadership in payroll and workforce management, strong float-driven income generation, and resilient, cash-rich business model. ADP’s stock price has depreciated by approximately 33.57% since our coverage due to a cooling U.S. labor market, which slowed payroll growth metrics, prompting analyst downgrades and negative sentiment after a revenue miss. madler934 shares a similar view but emphasizes Insperity, Inc. (NSP)’s earnings recovery potential driven by healthcare normalization and margin expansion.
Insperity, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 28 hedge fund portfolios held NSP at the end of the fourth quarter which was 32 in the previous quarter. While we acknowledge the risk and potential of NSP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NSP and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
